Exsera BioLabs

Exsera BioLabs brings unsurpassed expertise to the assessment of complement in adverse reactions to: immune complex, oligonucleotides, AAV, lipid nanoparticle or other inflammatory states. We balance that with an ability to accurately assess therapeutic inhibition of complement immunobiology. We excel in functional testing, activation measurements and multiplex analysis. Our Director is a recognized expert in the field having overseen countless studies and PI reports proving an unparalleled depth of knowledge and expertise. Combine that with a team with decades testing complement, Exsera BioLabs has the experience to understand your unique issues or complex results. Exsera is CAP/CLIA, FDA GLP & GCP compliant. Don’t know what you need from complement testing? We can also help with consultation and advising on your biomarker choice and study design.